Athira Pharma Inc. News
Latest updates and market news for ATHA
6 news
Dec 17 - Dec 23, 2025
Page 1
MT Newswires
Sector Update: Health Care Stocks Rise in Afternoon Trading
📊
AI Sentiment
Positive
7/10
MT Newswires
Wall Street Set to Open Higher Thursday as Inflation Rises Less Than Expected; Jobless Claims Decline
📊
AI Sentiment
Positive
7/10
MT Newswires
Investors Await Key Inflation, Employment Data as US Futures Rise Thursday Pre-Bell
âž–
AI Sentiment
Neutral
5/10
GlobeNewswire
Athira Pharma Announces Exclusive License to Lasofoxifene Phase 3 Development Program for Metastatic Breast Cancer Candidate and a Financing for up to $236 Million
📈
AI Sentiment
Highly Positive
9/10
Share this news page